References analysis of the Wikipedia article "Դեղորայքային ռեակցիա էոզինոֆիլիայով և համակարգային ախտանիշներով" in the Armenian version

doi.org

Walsh SA, Creamer D (January 2011). «Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking». Clinical and Experimental Dermatology. 36 (1): 6–11. doi:10.1111/j.1365-2230.2010.03967.x. PMID 21143513. S2CID 16048518.

Ganeva M, և այլք: (2008). «Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review». International Journal of Dermatology. 47 (8): 853–860. doi:10.1111/j.1365-4632.2008.03637.x. PMID 18717872. S2CID 34572606.

Adler NR, Aung AK, Ergen EN, Trubiano J, Goh MS, Phillips EJ (2017). «Recent advances in the understanding of severe cutaneous adverse reactions». The British Journal of Dermatology. 177 (5): 1234–1247. doi:10.1111/bjd.15423. PMC 5582023. PMID 28256714.

Cho YT, Yang CW, Chu CY (2017). «Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System». International Journal of Molecular Sciences. 18 (6): 1243. doi:10.3390/ijms18061243. PMC 5486066. PMID 28598363.

Bocquet H, Bagot M, Roujeau JC (December 1996). «Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)». Semin Cutan Med Surg. 15 (4): 250–7. doi:10.1016/S1085-5629(96)80038-1. PMID 9069593.

Saltzstein SL, Ackerman LV (1959). «Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas». Cancer. 12 (1): 164–82. doi:10.1002/1097-0142(195901/02)12:1<164::AID-CNCR2820120122>3.0.CO;2-Y. PMID 13618867. S2CID 27319054.

Corneli HM (2017). «DRESS Syndrome: Drug Reaction With Eosinophilia and Systemic Symptoms». Pediatric Emergency Care. 33 (7): 499–502. doi:10.1097/PEC.0000000000001188. PMID 28665896.

Thongsri T, Chularojanamontri L, Pichler WJ (March 2017). «Cardiac involvement in DRESS syndrome». Asian Pacific Journal of Allergy and Immunology. 35 (1): 3–10. doi:10.12932/AP0847. PMID 27996289.

Adwan MH (2017). «Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist». Current Rheumatology Reports. 19 (1): 3. doi:10.1007/s11926-017-0626-z. PMID 28138822. S2CID 10549742.

Chen, YC; Chiu, HC; Chu, CY (2010). «Drug reaction with eosinophilia and systemic symptoms: A retrospective study of 60 cases». Arch Dermatol. 146 (12): 1373–9. doi:10.1001/archdermatol.2010.198. PMID 20713773.

Spriet S, Banks TA (2015). «Drug reaction with eosinophilia and systemic symptoms syndrome». Allergy and Asthma Proceedings. 36 (6): 501–5. doi:10.2500/aap.2015.36.3903. PMID 26534757.

Nam YH, Park MR, Nam HJ, Lee SK, Kim KH, Roh MS, Um SJ, Son CH (2015). «Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised». Allergologia et Immunopathologia. 43 (1): 19–24. doi:10.1016/j.aller.2013.08.003. PMID 24388810.

Sauvetre G, MahÉvas M, Limal N, Guillaud C, Khellaf M, Bierling P, Languille L, Delbos F, Noizat-Pirenne F, Michel M, Godeau B (October 2015). «Cutaneous rash and dapsone-induced hypersensitivity syndrome a common manifestation in adult immune thrombocytopenia. Presentation and outcome in 16 cases». American Journal of Hematology. 90 (10): E201–2. doi:10.1002/ajh.24068. PMID 26120067.

Kardaun SH, Sidoroff A, Valeyrie-Allanore L, և այլք: (2007). «Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?». Response Br J Dermatol. 156 (3): 609–610. doi:10.1111/j.1365-2133.2006.07704.x. PMID 17300272. S2CID 32299525.

Shiohara T, Iijima M, Ikezawa Z, Hashimoto K (2007). «The diagnosis of DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations». Response Br J Dermatol. 156 (5): 1045–92. doi:10.1111/j.1365-2133.2007.07807.x. PMID 17381452. S2CID 33786375.

Blumenthal, Kimberly G.; Patil, Sarita U.; Long, Aidan A. (2012 թ․ ապրիլի 1). «The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome». Allergy and Asthma Proceedings. 33 (2): 165–171. doi:10.2500/aap.2012.33.3498. ISSN 1539-6304. PMID 22525393.

Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA, Phillips EJ (September 2017). «Pharmacogenomics of off-target adverse drug reactions». British Journal of Clinical Pharmacology. 83 (9): 1896–1911. doi:10.1111/bcp.13294. PMC 5555876. PMID 28345177.

Pavlos R, Mckinnon E, Ostrov D, Peters B, Buus S, Koelle D, Chopra A, Schutte R, Rive C, Redwood A, Restrepo S, Bracey A, Kaever T, Myers P, Speers E, Malaker S, Shabanowitz J, Yuan J, Gaudieri S, Hunt D, Carrington M, Haas D, Mallal S, Phillips E (2017). «Shared peptide binding of HLA class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles». Scientific Reports. 7 (1): 8653. Bibcode:2017NatSR...7.8653P. doi:10.1038/s41598-017-08876-0. PMC 5561238. PMID 28819312.

Mallal S, Phillips E, Carosi G, և այլք: (2008). «for the PREDICT-1 Study Team. HLA-B*5701 screening for abacavir hypersensitivity». N Engl J Med. 358 (6): 568–579. doi:10.1056/nejmoa0706135. PMID 18256392.

Konvinse KC, Trubiano JA, Pavlos R, James I, Shaffer CM, Bejan CA, Schutte RJ, Ostrov DA, Pilkinton MA, Rosenbach M, Zwerner JP, Williams KB, Bourke J, Martinez P, Rawandamuriye F, Chopra A, Watson M, Redwood AJ, White KD, Mallal SA, Phillips EJ (2019). «HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms». J Allergy Clin Immunol. 144 (1): 183–192. doi:10.1016/j.jaci.2019.01.045. PMC 6612297. PMID 30776417.

Hoetzenecker W, Nägeli M, Mehra ET, Jensen AN, Saulite I, Schmid-Grendelmeier P, Guenova E, Cozzio A, French LE (2016). «Adverse cutaneous drug eruptions: current understanding». Seminars in Immunopathology. 38 (1): 75–86. doi:10.1007/s00281-015-0540-2. PMID 26553194. S2CID 333724.

Feldmeyer L, Heidemeyer K, Yawalkar N (2016). «Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy». International Journal of Molecular Sciences. 17 (8): 1214. doi:10.3390/ijms17081214. PMC 5000612. PMID 27472323.

Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O (2017). «Severe cutaneous adverse reactions to drugs». Lancet. 390 (10106): 1996–2011. doi:10.1016/S0140-6736(16)30378-6. PMID 28476287. S2CID 9506967.

Bachelez H (January 2018). «Pustular psoriasis and related pustular skin diseases». The British Journal of Dermatology. 178 (3): 614–618. doi:10.1111/bjd.16232. PMID 29333670. S2CID 4436573.

Pichler WJ, Hausmann O (2016). «Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms». International Archives of Allergy and Immunology. 171 (3–4): 166–179. doi:10.1159/000453265. PMID 27960170.

Wang CW, Dao RL, Chung WH (2016). «Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions». Current Opinion in Allergy and Clinical Immunology. 16 (4): 339–45. doi:10.1097/ACI.0000000000000286. PMID 27362322. S2CID 9183824.

Chung WH, Wang CW, Dao RL (2016). «Severe cutaneous adverse drug reactions». The Journal of Dermatology. 43 (7): 758–66. doi:10.1111/1346-8138.13430. PMID 27154258. S2CID 45524211.

Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T (2017). «Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis». Clinical Reviews in Allergy & Immunology. 54 (1): 147–176. doi:10.1007/s12016-017-8654-z. PMID 29188475. S2CID 46796285.

Chong HY, Mohamed Z, Tan LL, Wu DB, Shabaruddin FH, Dahlui M, Apalasamy YD, Snyder SR, Williams MS, Hao J, Cavallari LH, Chaiyakunapruk N (2017). «Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia». The British Journal of Dermatology. 177 (4): 1102–1112. doi:10.1111/bjd.15498. PMC 5617756. PMID 28346659.

Su SC, Hung SI, Fan WL, Dao RL, Chung WH (2016). «Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation». International Journal of Molecular Sciences. 17 (11): 1890. doi:10.3390/ijms17111890. PMC 5133889. PMID 27854302.

nih.gov

pubmed.ncbi.nlm.nih.gov

Corneli HM (2017). «DRESS Syndrome: Drug Reaction With Eosinophilia and Systemic Symptoms». Pediatric Emergency Care. 33 (7): 499–502. doi:10.1097/PEC.0000000000001188. PMID 28665896.

Spriet S, Banks TA (2015). «Drug reaction with eosinophilia and systemic symptoms syndrome». Allergy and Asthma Proceedings. 36 (6): 501–5. doi:10.2500/aap.2015.36.3903. PMID 26534757.

Allam, JP; Paus T; Reichel C; և այլք: (Sep–Oct 2004). «DRESS syndrome associated with carbamazepine and phenytoin». European Journal of Dermatology. 14 (5): 339–342. PMID 15358574.

Markel, A (October 2005). «Allopurinol-induced DRESS syndrome» (PDF). Israel Medical Association Journal. 7 (10): 656–660. PMID 16259349. Արխիվացված է օրիգինալից (PDF) 2020 թ․ նոյեմբերի 28-ին. Վերցված է 2009 թ․ փետրվարի 3-ին.

Chung WH, Wang CW, Dao RL (2016). «Severe cutaneous adverse drug reactions». The Journal of Dermatology. 43 (7): 758–66. doi:10.1111/1346-8138.13430. PMID 27154258. S2CID 45524211.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

Chung WH, Wang CW, Dao RL (2016). «Severe cutaneous adverse drug reactions». The Journal of Dermatology. 43 (7): 758–66. doi:10.1111/1346-8138.13430. PMID 27154258. S2CID 45524211.

worldcat.org

Դեղորայքային ռեակցիա էոզինոֆիլիայով և համակարգային ախտանիշներով (Armenian Wikipedia)

archive.org

dermnetnz.org

doi.org

fda.gov

harvard.edu

ui.adsabs.harvard.edu

ima.org.il

john-libbey-eurotext.fr

murdoch.edu.au

researchrepository.murdoch.edu.au

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

web.archive.org

worldcat.org